Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-07
1996-01-02
Killos, Paul J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A01N 4338
Patent
active
054809010
ABSTRACT:
A conjugate comprising a drug which has an inhibitory effect on cellular adhesion and a lipophilic cell binding agent, when applied to a compromised site, e.g., due to surgical intervention, injury, chemotherapy, disease or inflammation, is effective in reducing unwanted adhesion formation.
REFERENCES:
Carlson R et al Org. Mass Spectrom, (1994) 29(11) 632-40.
Spink, C et al Biochem, Biophys. Acta (1994) 1191(1) 164-72.
DeClerck, L. et al J. Immunol Methods (1994) 172(1) 115-24.
Baker Margaret A.
Ohlsson-Wilhelm Betsy M.
Killos Paul J.
Zynaxis, Inc.
LandOfFree
Method for reducing unwanted cellular adhesions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing unwanted cellular adhesions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing unwanted cellular adhesions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-235482